磷酸肌酸联合脑循环治疗仪治疗急性脑梗死疗效观察

目的观察磷酸肌酸联合脑循环治疗仪治疗急性脑梗死的有效性。方法218例急性脑梗死患者随机分为治疗组（n=109）和对照组（H=109），治疗组在常规治疗基础上加用磷酸肌酸钠1g，每日两次，脑循环治疗仪治疗每日1次，疗程均为14d，观察两组治疗前后神经功能缺损评分。结果两组治疗后神经功能缺损评分均有改善，治疗组优于对照组，两组比较差异有统计学意义（P〈0．01）；治疗组有效率为90．8％，对照组有效率为75．2％，两组有效率比较，差异有统计学意义（P〈0．01）。结论应用磷酸肌酸联合脑循环治疗仪治疗急性脑梗死有明显疗效。

Efficacy of phosphocreatine and cerebrovascular function therapy in the treatment of acute cerebral infarction

Objective To observe the efficiency of phosphocreatine and cerebral circulation therapeutic apparatus in the treatment of acute cerebral infarction. Methods A total of 218 cases of patients with acute cerebral infarction were randomly divided into treatment group （n = 109） and control group （n = 109）. The patients in treatment group were given phosphocreatine lg semidaily and cerebrovascular function therapy once a day besides conventional therapy which was given in control group only. Both groups were assessed with neural function defect scores before and after 14 days treatment. Results After treatment in two groups, the neural function defect scores were improved, and the treatment group was superior to the control group. There was statistically significant difference between two groups （P 〈 0.01）. The effective rate in treatment group was 90.8670 and the control group was 75.2%, and the difference was sta- tistically significant （P 〈 0.01）. Conclusion The application of phosphocreatine and cerebrovascular function therapy in the treatment of acute cerebral infarction has obvious curative effect.